IVA is Inventiva S.A. (Healthcare) — a non-dividend-paying stock. Trading at $4.86. Market cap: $1.13B.
Stock snapshot
| Price | $4.86 |
| Market cap | $1.13B |
| Sector | Healthcare |
| Exchange | NGM |
| Pays dividend | No |
About IVA
Inventiva SA is a France-based clinical-stage biopharmaceutical company focused on the development of oral small-molecule therapies for the treatment of MASH. The wholly-owned research and development facility and a team with expertise and experience in the development of compounds that target nuclear receptors, transcription factors and epigenetic modulation. Leveraging the expertise, the company is also advancing lanifibranor for the treatment of MASH and has a pipeline of earlier-stage therapeutic programs in oncology. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France.
Frequently asked
What is IVA's current stock price?
IVA (Inventiva S.A.) is currently trading at $4.86.
Does IVA pay a dividend?
IVA (Inventiva S.A.) does not currently pay a regular dividend.
Track IVA in DiviDrip
Add IVA to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.
- Open DiviDrip — search IVA and add it to your watchlist.
- Stock Screener — filter by sector, market cap, and Capital Quality Rank.
- How to use the Screener — sector / quality / market-cap filters explained.
Data refreshed 2026-09-03. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.